136 related articles for article (PubMed ID: 1531856)
1. Low density lipoprotein receptor pathway in the delivery of Photofrin: how much is it relevant for selective accumulation of the photosensitizer in tumors?
Korbelik M
J Photochem Photobiol B; 1992 Jan; 12(1):107-9. PubMed ID: 1531856
[No Abstract] [Full Text] [Related]
2. Photosensitizer-protein conjugates: potential use as photoimmunotherapeutic agents.
Wat CK; Mew D; Levy JG; Towers GH
Prog Clin Biol Res; 1984; 170():351-9. PubMed ID: 6241684
[No Abstract] [Full Text] [Related]
3. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
[TBL] [Abstract][Full Text] [Related]
4. [Topical administration of hematoporphyrin derivative and red light irradiation. A therapeutic approach in psoriasis].
Monfrecola G; Mangone S; Procaccini EM; Santoianni P
G Ital Dermatol Venereol; 1988 Dec; 123(12):671-4. PubMed ID: 2978159
[No Abstract] [Full Text] [Related]
5. A comparison of serum kinetics and tissue distribution of photofrin II following intravenous and intraperitoneal injection in the mouse.
Pantelides ML; Moore JV; Blacklock NJ
Photochem Photobiol; 1989 Jan; 49(1):67-70. PubMed ID: 2524073
[No Abstract] [Full Text] [Related]
6. [Molecular biological mechanisms of photodynamic therapy].
Kirvialene VA; Lukshene ZhB; Iuodka BA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1989; (5):5-14. PubMed ID: 2527567
[TBL] [Abstract][Full Text] [Related]
7. Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
Vitols S
Cancer Cells; 1991 Dec; 3(12):488-95. PubMed ID: 1840290
[TBL] [Abstract][Full Text] [Related]
8. Photoradiation therapy.
Dougherty TJ
Urology; 1984 Mar; 23(3 Suppl):61-4. PubMed ID: 6230788
[No Abstract] [Full Text] [Related]
9. Photodynamic therapy of the canine peritoneum: normal tissue response to intraperitoneal and intravenous photofrin followed by 630 nm light.
Tochner Z; Mitchell JB; Hoekstra HJ; Smith P; DeLuca AM; Barnes M; Harrington F; Manyak M; Russo D; Russo A
Lasers Surg Med; 1991; 11(2):158-64. PubMed ID: 1827854
[TBL] [Abstract][Full Text] [Related]
10. [Percutaneous absorption of hematoporphyrin derivative--fluorescence- and electron microscopic studies].
Preś H; Meffert H; Barthelmes H; Klug H; Sönnichsen N
Dermatol Monatsschr; 1990; 176(8):461-8. PubMed ID: 2146175
[TBL] [Abstract][Full Text] [Related]
11. Preface: hematoporphyrin derivative photoradiation therapy.
Berns MW
Lasers Surg Med; 1984; 4(1):1-4. PubMed ID: 6235410
[No Abstract] [Full Text] [Related]
12. Clinical use of hematoporphyrin derivative in malignant tumors.
Ha XW; Sun XM; Xie JG; Fan XJ; Zhang YH; Mei QC; Shen H; Xu SL; Zhang RG
Chin Med J (Engl); 1983 Oct; 96(10):754-8. PubMed ID: 6233105
[No Abstract] [Full Text] [Related]
13. [Hematoporphyrin derivative (HpD) and laser therapy in the management of malignant tumors--clinical analysis of 47 cases].
Ha XW
Zhonghua Yi Xue Za Zhi; 1983 Jun; 63(6):322-5. PubMed ID: 6226341
[No Abstract] [Full Text] [Related]
14. In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts.
Candide C; Morlière P; Mazière JC; Goldstein S; Santus R; Dubertret L; Reyftmann JP; Polonovski J
FEBS Lett; 1986 Oct; 207(1):133-8. PubMed ID: 2945739
[TBL] [Abstract][Full Text] [Related]
15. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours.
Mazière JC; Morlière P; Santus R
J Photochem Photobiol B; 1991 Mar; 8(4):351-60. PubMed ID: 1904487
[TBL] [Abstract][Full Text] [Related]
16. [Comparison on the biological activity of three home-made HpDs with that of photofrin II].
Han R; Xu CX; Li ZR; Cheng YS; Du CZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):159-64. PubMed ID: 2946453
[No Abstract] [Full Text] [Related]
17. [The pharmacokinetics of hematoporphyrin, its derivative and fluorescein during the development of carcinosarcoma].
Barabash RD; Skobelkin OK; Petukhov MI; Normanskiĭ VE; Riazhskiĭ GG; Mironova MI; Andreeva KP; Kolobanov AS
Farmakol Toksikol; 1990; 53(3):24-6. PubMed ID: 2143733
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry methods in photoradiation therapy.
Profio AE; Wudl LR; Sarnaik J
Adv Exp Med Biol; 1985; 193():35-41. PubMed ID: 2937269
[No Abstract] [Full Text] [Related]
19. Use of hematoporphyrin in photodynamic therapy.
Dougherty TJ
J Photochem Photobiol B; 1991 Mar; 8(4):439. PubMed ID: 1828502
[No Abstract] [Full Text] [Related]
20. Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy.
Kessel D
Photochem Photobiol; 1984 Jun; 39(6):851-9. PubMed ID: 6235529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
